Protein A Chromatography Ligands for Alkaline CIP Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing chromatography ligands, particularly those based on Staphylococcal protein A (SpA), are not stable under alkaline conditions, making them unsuitable for repeated cleaning-in-place (CIP) cycles, which are necessary for maintaining selectivity and binding capacity, especially in large-scale immunoglobulin purification.
Innovation Solution
Development of alkaline-stable SpA-based chromatography ligands comprising multiple domains of SpA, such as two or more B or Z domains, attached to a chromatography resin at multiple sites, and modified with specific amino acid mutations at position n+1, enhancing their resistance to alkaline cleaning.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional protein A-ligands are used in chromatography matrices, then high selectivity and binding capacity for immunoglobulins are achieved, but the ligands are not stable under alkaline cleaning conditions and cannot withstand repeated CIP cycles
Solution Approach 1:
The patent applies parameter changes by modifying the amino acid sequence of protein A ligands, specifically replacing susceptible residues (asparagine, glutamine, serine, cysteine) at positions n, n+1, and n+2 with alkaline-stable amino acids (alanine, glycine, valine, leucine, isoleucine, methionine, proline, phenylalanine, tyrosine, tryptophan, histidine, arginine, lysine). This chemical parameter modification enables the ligands to withstand repeated alkaline cleaning cycles while maintaining binding capacity.
Solution Approach 2:
The patent creates composite structures by combining multiple stabilized protein A ligand variants on a single chromatography matrix support. The matrix comprises a solid support with immobilized protein A ligands that have been engineered with specific amino acid substitutions, creating a composite material that integrates the stabilizing effects of multiple modified residues to achieve superior alkaline stability and extended service life under CIP cycles.
2Manufacturing precision
If harsh alkaline cleaning (1M NaOH, pH 14) is applied to maintain selectivity and binding capacity, then the chromatography matrix is restored, but protein-based ligands are damaged and lose functionality
Solution Approach 1:
The patent applies preliminary anti-action by pre-modifying the protein A ligand structure with alkaline-stable amino acid substitutions before exposure to harsh cleaning conditions. This preventive structural modification counteracts the damaging effects of 1M NaOH treatment, allowing the ligands to withstand the harsh cleaning protocol without degradation and maintain their binding capacity over extended periods.
3Reliability
If repeated cleaning-in-place cycles are performed to maintain ligand performance, then selectivity and binding capacity are preserved, but the frequency of ligand replacement increases due to degradation
Solution Approach 1:
The patent applies parameter changes by modifying the chemical composition of the ligand through amino acid substitution, replacing residues susceptible to alkaline degradation with stable alternatives. This parameter modification reduces ligand loss during repeated CIP cycles while maintaining the selectivity required for effective immunoglobulin purification.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The alkaline-stable ligands retain at least 95% of their binding capacity after prolonged exposure to alkaline solutions, ensuring effective and cost-effective large-scale purification of immunoglobulins.
Implementation Method 1
Staphylococcal protein A (SpA) based reagents and chromatography matrices have found a widespread use in the field of affinity chromatography for capture and purification of antibodies due to its ability to bind IgG
Data Source
AI summary
The present invention relates to chromatography ligands having improved caustic stability, e.g., ligands based on immunoglobulin-binding proteins such as, Staphylococcal protein A, as well as methods of making and using such ligands.